Category Archives: Publications

19 Dec

Big Government vs. Everyone Else: The Truth About the Bizarre World of Drug Benefit Programs in Canada

Publications
0 Comments
By
In the Globe and Mail’s Report on Business (ROB) dated November 2016 there appeared an eight-page report entitled, “Big Pharma vs. Everyone”. Below is a counterpoint article to the one found in ROB. It has been written to set the record straight and to inform Canadians accurately about the pharmaceutical system and the difficulty in
18 Oct

Four persistent rural healthcare challenges

Publications
0 Comments
By
Today, 25% of Canadians live in rural and remote parts of Canada. The evidence is that these Canadians do not enjoy the same health status as citizens living in more urban settings. This article explores four persistent healthcare challenges: population demographics, place, professionals, and public participation. By exploring solutions that some rural communities have used
28 Sep

Continence training needs assessment of residential long-term care personal support workers

Publications
0 Comments
By
Urinary incontinence (UI) and fecal incontinence (FI) are embarrassing and debilitating conditions that are becoming collectively a major, growing health concern for men and women of all ages worldwide. In terms of academic study, interest and understanding, fecal incontinence (FI) is the poor cousin of the incontinence twins. Recent research from the Canadian Continence Foundation
26 Jun

Rule of Law and State Capacity: Keys to Market Access in Developing and Resource-Constrained Markets

Publications
0 Comments
By
Despite the availability of essential medicines in developing countries, one-third of the world’s population does not have access to essential medicines due to barriers including money, power, politics, and ideologies. Market failures and lack of political will to create stable, ethical and law-abiding government administrations that can support infrastructure and resources should carry a significant amount
20 Jun

5 Principles, 4 Pharmacare Models, 1Panacea?

Publications
0 Comments
By
Pharmaceutical models being touted for Canada do more harm than good for patients in need of innovative but expensive care. The following slides are from The Cameron Institute executive director Wayne Taylor’s presentation to the Best Medicine Coalition’s recent annual conference.
10 Jun

Canada’s Self-Defeating Attack on Innovation

Publications
0 Comments
By
By Philip Stevens & Mark Schultz Over the last decade, it’s become increasingly difficult for pharmaceutical companies to protect their intellectual property rights in Canada. Canadian courts have invalidated over 25 patents since 2005 because the inventor did not have proof that widely prescribed medicines performed exactly as predicted in the original patent application. Canada’s
08 Jun

Provincial Catastrophic and Disease-specific Drug Plans – Comparisons in Mediocrity

Publications
0 Comments
By
The Cameron Institute believes that it is time for the national government of Canada to help patients by supporting or backstopping health system payors, public and private, to enable individuals to afford the high cost of drugs that are targeted to treat debilitating and often life-threatening conditions. This document shows that existing provincial catastrophic and
30 Mar

Putting children first: An opportunity for Canada’s new government

Publications
0 Comments
By
For more than 50 years, the importance of studying new medicines in childhood has been widely recognized. Nonetheless, Health Canada has eschewed policies requiring such evaluation, despite effective reforms elsewhere. In 2012, the Council of Canadian Academies convened an expert panel to assess Canada’s research base for labelling of pediatric therapies. The September 2014 report